Download CONGRESS PROGRAMME THURSDAY, 28 APRIL

2nd ASPIC International Congress, 28 - 29 April, Porto
CONGRESS PROGRAMME
THURSDAY, 28 APRIL
09.00
Opening Session
Symposium II
Symposium
EARLY CANCER
DETECTION
TUMOUR
IMMUNOLOGY
Chairs: José
António
Dias
Pereira,Demengeot
Carla Oliveira
Chairs:
Dinis,
Jocelyne
12.30
Paulo Rodrigues-Santos . Portugal
PD-1 downregulation on Tregs during Tyrosine Kinase
Inhibitor therapy in Chronic Myeloid Leukemia
13.00
Lunch
14.00
Poster Parallel Sessions
Chairs: A.T. Maia, A. Preto, F. Carneiro, G.
Sousa, I. Fonseca, M. Damasceno, M.J.
Cardoso, M.J. Bento, N. Lunet, N. Sousa,
R. Seruca, R. Henrique, S. Socorro
16.00
Coffee-break
INVITED SPEAKERS
09.30
Bruno Silva Santos . Portugal
Gamma-delta T lymphocytes in the tumour environment:
from oncoimmunology to adoptive cell immunotherapy.
10.00
Jolanda de Vries . Netherlands
Harnessing adaptive immune responses in hereditary
cancer.
SELECTED SPEAKERS
10.30
Célia Gomes . Portugal
Natural Killer cell-based adoptive immunotherapy
eradicates and promotes the differentiation of
chemoresistant stem-like cells.
10.45
Karine Serre . Portugal
Tumour-associated neutrophils inhibit pro-tumour IL17producing gamma-delta T cells.
11.00
Coffee-break
Symposium
Symposium IIII
NEW
RESEARCH APPROACHES
FROM ASPIC –ASEICA
IMMUNOMODULATION
OF CANCER
Chairs: Bruno Silva Santos, Júlio Oliveira
INVITED SPEAKERS
11.30
Frederick Arce Vargas . United Kingdom
Targeting immune regulation in the tumour site.
12.00
Jeffrey Weber . United States
Efficacy and Biomarker Analyses of the Use of Checkpoint
Inhibition in Melanoma.
SELECTED SPEAKERS
12.30
Ana Catarina Pinho . Portugal
Functional capacity of tumor lysate-pulsed monocytederived dendritic cells inducing in vitro immune responses
Symposium III
RADIATION BIOLOGY AND RADIOTHERAPY
Chairs: Luísa Carvalho, Pedro Almeida
INVITED SPEAKERS
16.30
Rolf Lewensohn . Sweden
Molecular tumour response to accelerated ions and role
of cellular modifying factors.
17.00
Marie Dutreix . France
Focus on the combination of DNA repair inhibitors with
radiotherapy.
SELECTED SPEAKERS
17.30
Paula Boaventura . Portugal
TERT promoter mutations in thyroid carcinoma from
childhood irradiated tinea capitis patients.
17.45
Ana T. Pinto . Portugal
Macrophages modulate colorectal cancer cell response
to radiation.
18.00
19:00
ASPIC General Assembly
20.00
Congress Dinner
2nd ASPIC International Congress, 28 - 29 April, Porto
FRIDAY, 29 APRIL
Symposium
III IV
Symposium
CANCER
GENES:
WHAT DID
LEARN FROM
THEM?
SIGNALING
PATHWAYS:
THEWE
ANDROGEN
RECEPTOR
MODELSergio Dias, João Nuno Moreira
Chair:
Chairs: Carmen Jerónimo, Nuno Sousa
INVITED SPEAKERS
09.30
Wytske van Weerden . Netherlands
The continued role of AR in castration-resistant prostate
cancer.
10.00
Tiffany Traina . United States
The role of the AR in advanced breast cancer.
13.00
Lunch
MECHANISMS
AND IMPLICATIONS OF TUMOUR
PLENARY LECTURES
HETEROGENEITY
Chairs: Manuel Sobrinho Simões, Nuno Miranda,
Jorge Soares, Carlos Camps
ASPIC Lecture
14.00
Alberto Cambrosio . Canada
Mapping the development of Portuguese clinical research
in oncology.
ASEICA Lecture
SELECTED SPEAKERS
14.45
10.30
Cristina Amaral . Portugal
Estrogen-dependent breast cancer: the involvement of
androgen receptor in exemestane-acquired resistance.
10.45
Inês Graça . Portugal
Androgen Receptor mediates castration-resistant
prostate cancer cells response to the DNMT inhibitor
Hydralazine.
EACR Lecture
15.30
Coffee-break
Richard Marais . United Kingdom
RAS and RAF signalling in melanoma: from basic biology
to clinical responses.
16.15
11.00
Luis Paz Ares . Spain
Lung cancer precision treatment.
Closing Session
Research Trial / Pixels Brand Oral Presentation Prize
EACR Poster Prizes
Symposium V
CELL AND TUMOUR BIOLOGY
Chairs: Luís Costa, Fátima Baltazar
INVITED SPEAKERS
11.30
Gunther Boysen . United Kingdom
Molecular features of SPOP mutant/ CHD1 deleted prostate
cancer.
12.00
Joan Seoane . Spain
Tackling intratumour heterogeneity in brain tumors.
SELECTED SPEAKERS
12.30
Joana Vieira de Castro . Portugal
Autofluorescence as a new biomarker to identify
Glioblastoma Stem Cells.
12.45
Ana Sofia Ribeiro . Portugal
P-cadherin, a therapy predictive biomarker for Dasatinib
in basal-like triple negative breast cancer.
OLI Poster Prizes